Patients with a history of tuberculosis are at risk for developing osteoporosis or osteoporotic fractures.
Maternal vaccination of tetanus-diphtheria-acellular pertussis (Tdap) was found to be more effective in the second rather than the third trimester of pregnancy.
Patients with type 2 diabetes may be at greater risk of developing community-acquired pneumonia when using thiazolidinediones with metformin compared to treatment with a sulfonylurea and metformin.
Individuals with certain occupations or in certain populations may be more at risk of fatality from hantavirus pulmonary syndrome.
Risk for pneumonia should be considered when weighing the benefits and risks of benzodiazepines in patients with Alzheimer disease.
New antibiotic therapy is associated with greater likelihood of recovery after acute lung function decline in children with cystic fibrosis.
Paratek announced positive outcomes for their phase 3 trial of omadacycline for treating community-acquired bacterial pneumonia.
Vaccination reduces influenza-associated death in children with overall effectiveness of 65%.
Maternal Tdap vaccination was found to be highly protective against pertussis in newborns.
The first RCT of high-flow warm humidified oxygen (HFWHO) compared to low-flow cold cannula oxygen showed HFWHO was safe and more effective when used after failed standard therapy.
Age, male gender, underlying cerebrovascular disease, chronic pulmonary disease, congestive heart failure, diabetes mellitus, and usage of antipsychotics were independent risk factors of pneumonia among dementia patients with PPI usage.
Elevated cardiac troponin levels were highly predictive of both in-hospital and long-term mortality in patients admitted for community-acquired pneumonia (CAP).
Rhinovirus detection in the lower respiratory tract had high mortality rates comparable to viral pneumonia associated with other well-established respiratory viruses.
Although published guidelines recommend amoxicillin in most children with community-acquired pneumonia, due to nonclinical factors, macrolides and broad-spectrum antibiotics continue to be prescribed.
Interrupting the transmission of extensively drug-resistant tuberculosis is the most important factor in curtailing the epidemic areas of high disease burden.
Researchers observed a 95.3% reduction of S pneumoniae bacteremia after implementation of routine immunization with the pneumococcal conjugate vaccine.
At this time, no vaccine to prevent or drug to treat respiratory syncytial virus infection is available.
First study to examine the benefit of treating GERD with proton pump inhibitors in reducing the acute respiratory infections complications.
Intravenous zanamivir is as safe and efficacious as oral oseltamivir in hospitalized patients with severe influenza.
Inhaled corticosteroids use may not increase risk of pneumonia or other respiratory infections in children with asthma.
The most common factor used to identify risk for early onset sepsis was obstetric diagnosis of chorioamnionitis, according to the study.
Test uses procalcitonin as a biomarker to help make antibiotic management decisions in patients with lower respiratory tract infections and sepsis.
The cysteinyl leukotriene pathway may be a therapeutic target in future research preventing morbidity associated with severe influenza A virus infection.
Vitamin D supplementation may prevent acute respiratory tract infections, according to a recent study.
For the predominant circulating influenza A type H3N2 flu strain, the vaccine effectiveness comes in at 43%.
Vaccination may be able to prevent significant morbidity and mortality associated with heart failure, according to a study.
According to a new 7-year observational study, use of nonsteroidal anti-inflammatory drugs (NSAIDs) during acute respiratory infection may significantly increase the risk of heart attack.
A Cochrane review found that polyvalent pneumococcal vaccines offered significant protection against CAP in patients with COPD but did not lower the risk of confirmed pneumococcal pneumonia.
Contrary to previous studies, this study found an increased hospitalization risk for community-acquired pneumonia with higher-potency vs lower-potency statins.
The most common strain is H3N2, which is contained in the 2016-2017 influenza vaccine.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- New Guideline on HPV Vaccine for Cervical Cancer Prevention
- Tetravalent E coli Vaccine Safe, Immunogenic in Women With Recurrent UTI
- New Bill Before Congress Aims at Addressing Antibiotic Resistance Problem
- Statins Reduce Risk of Cirrhosis Decompensation in HBV, HCV
- Informed Consent in Medical Research in the Digital Age
- The Handoff: Your Week in Infectious Disease News - 4/28/17
- Tuberculosis Increases Risk of Osteoporosis, Osteoporotic Fractures
- Pertussis Booster Dose Safe in Pediatric Patients With IBD
- Ophthalmic Exam Recommended in Infants With Congenital Zika Syndrome
- Does Use of Azithromycin Increase Risk of Ventricular Arrhythmia?